Top 50 Medical VC Funds & Investors in Finland (July 2026)

Portfolio highlights

• Skyfora — Skyfora delivers sub-kilometer insights, nowcasts, and probabilistic forecasts so your teams can plan with confidence, no matter the weather.
• Rotomate — Turn machine data into clear maintenance decisions, at scale. Rotomate's AI Engineer monitors every asset so your team knows what to act on.
• Raisio plc — Raisio plc develops, manufactures, and markets foods, functional food ingredients, and animal feeds in Finland, Great Britain, rest of Europe, and internationally. It operates through two segments, Brands and Raisioagro. It offers snacks and cereals products, such as oat flakes, instant porridges, and snack biscuits and drinks under the Elovenabrand name; cereal bars under the Harvest Cheweee brand; sugar puffs under the Honey Monster brand name; flakes and porridges under the Nalle brand; grain-based products under the Nordic brand.

Portfolio highlights

• ARAUCO — ARAUCO is a diversified global company in the forestry industry. They use world-class technologies and processes throughout the value chain. They are present in the forestry, pulp, timber, panels and renewable energy businesses.
• Volare — Refining food industry side streams into sustainable protein, oil and fertilizers.
• CHAOS — CHAOS is an urban forecasting company for real estate investors and city developers. Our AI platform processes urban data and crowd insights to forecast investment and development for creating liveable cities.

Portfolio highlights

• Nucu — The Nucu Pad is a multisensory baby pad that soothes your baby to sleep with womb-like feelscapes.
• Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
• Sofi Filtration — Innovation in Industrial Liquid Filtration

Portfolio highlights

• ICEYE — Gain access to timely and reliable SAR imaging from the world's leading New Space SAR satellite constellation.
• Thor Dynamics — Headquartered in Orlando, Florida, with a European base in Finland, Thor Dynamics specializes in directed energy systems for defense against drones and drone swarms. The company’s innovative solutions are available worldwide to protect critical infrastructure and enhance national security. Laser Armor™ is a complete directed energy counter-dronesolution. Utilizing advanced radar and optical systems it can detect, track, and target hostile targets. High-power directed energy from Thor’s Laser Engines then eliminates the threat in seconds. Multiple safety systems ensure accurate target identification and minimal collateral damage.
• Everywear Games — Metacore is a wearable game studio. The company was founded in 2014 by industry veterans from Remedy, Digital Chocolate and Rovio and it is the pioneer of smartwatch gaming. It’s award-winning Apple Watch launch title, Runeblade, has received worldwide recognition from press, fans and industry heavyweights and it’s games are consistently on top ofglobal charts.

Portfolio highlights

• Disior — At Disior, we build software to measure and model tissue structures in CT- and MRI-images for better diagnosis and treatment planning.Our solutions are for clinical use. They enable fast, accurate and reproducible measuring for diagnostics and patient-specific, optimized treatment planning. Based on mathematical modelling, Disior algorithmsextract the correct shape or structure from the medical image. This way, the software is not dependent on finding familiar structures or comparing something to reference data. We combine engineering and R&D talent with medical and biotechnology professionals. Our team brings together decades of experience in creating world’s best simulation and modelling systems from smartphone R&D; clinicians and researchers in maxillofacial and orthopedics; and technology innovation and commercialization.For demo, pilots and research projects, please contact Anna-Maria Henell, CEO: +358 50 483 6433 / anna-maria (at) disior.com
• IXI — Discover adaptive glasses with autofocus lenses that adjust to your viewing needs, providing seamless clarity at any distance.
• K Line Europe — Clear Aligner solutions made in Germany for dentists, orthodontists and laboratories.

Portfolio highlights

• Cytely — Transforms microscopy from image-driven to data-driven through AI-powered autonomous targeting that captures high-resolution data of critical cellular events, enabling researchers to solve complex biological problems in minutes instead of years.
• Oplane — Oplane AB is a cybersecurity startup that develops an AI powered platform for automated threat modeling for software development teams.
• ReOrbit — Looking for a way to keep your data flowing in space? ReOrbit has you covered with our line of autonomous and inter-networking satellites!

Portfolio highlights

• Jaakko.com — Reinventing the housing market with no agents, more homes, and less fees.
• Retailgrid — Retailgrid is an AI-powered retail workspace that enables pricing, merchandising, and commercial teams to analyze data, run simulations, and make decisions in real time. Combining a flexible spreadsheet-like interface with AI agents, RetailGrid replaces fragmented tools and manual workflows with a single system for pricing optimization, promotionplanning, and assortment decisions. The platform connects to product, sales, and competitor data, automatically generates insights, and allows teams to test scenarios and deploy decisions at scale. RetailGrid is built for data-driven retailers looking to move faster and operate with the efficiency of top-tier consulting, without the cost or complexity.
• Bahn Express — Bahn Express is a global car transportation company that supports independent contractors while offering quick and easy auto shipping throughout Europe.

Portfolio highlights

• Valpas — Valpas is the hygiene protocol that reassures your future guests and keeps your hotel clean from the most uncontrollable: bed bugs
• Videoly — The easiest way for online retailers to get hand-picked and automatically embedded product videos.
• allies.digital — Allies is a match-making platform curating businesses with IT-, digital and creative agencies. No more miss-matches when buying IT & creative services.

Portfolio highlights

• Zenniz — Zenniz is an ITF approved game tracking solution that provides real-time info, such as automated line calling, stroke and serve speeds, shot charts, match statistics and more. Players and coaches at all levels can use Zenniz on and off the court to help improve their game. For tennis clubs, Zenniz is an easy and cost-effective way to upgrade to thenext level. Due to a new, innovative sensor technology, they’ve been able to keep the cost to a minimum, making Zenniz accessible for all clubs, coaches and players.
• CooliBlade — Superior power electronics cooling solutions for applications like solar and wind energy, energy storage, EV charging and telecommunications.
• Polar Light Technologies — Polar Light Technologies focuses on developing the next generation of Nano and micro LED technology.

Portfolio highlights

• CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
• mu-ray.tech — Mu-ray.tech is focused on advancing the field of medical diagnostics and industrial quality control. mu-ray.tech is developing a groundbreaking technology for the rapid, safe and accurate 3D-imaging of the chemical composition of scanned objects, serving critical needs in industrial quality control and medical diagnostics. The technology is basedon Muon Beam Imaging (MBI), an innovative technology leveraging Laser Plasma Accelerator-based artificial muon sources, new generation particle detector systems and AI. In industry, we are working with the partners in the heavy, aerospace, and defence domains.mu-ray.tech operates at the three sites: DESY in Hamburg (hardware), Tehnopol in Tallinn (algorithms and software), and Bradfield Centre in Cambridge (algorithms, business development). Our main collaboration on the MBI technology partners are GScan in Estonia and UK, DESY in Hamburg, the University of Cambridge, and KBFI in Tallinn.
• Perfat Technologies — Perfat Technologies is a health-based technology company that develops fat-management applications based on healthy vegetable oils.

Portfolio highlights

• ReOrbit — Looking for a way to keep your data flowing in space? ReOrbit has you covered with our line of autonomous and inter-networking satellites!
• MedicubeX — MedicubeX aims to revolutionize preventive healthcare by building a network of autonomous self-measurement and telehealth eHealth Stations. We are the most advanced health kiosk and the first one in the Nordics. The eHealth Station offers regular clinical-grade medical check-ups for everyone regardless of location.
• CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.

Portfolio highlights

• Fiagon —
• Surgify — Surgify are currently preparing the commercialization of a novel technology for bone surgery at Aalto University with financial support from Tekes (Finnish Funding Agency for Innovation). To enable continuous communication with clinicians, they have been working in close cooperation with Neurosurgical Department of Helsinki University CentralHospital, part of HUS (The Hospital District of Helsinki and Uusimaa).
• SurgicEye — SurgicEye designs intra-operative imaging and instrument navigation solutions for surgical procedures. It offers a navigated radio-guided surgery based on the handheld 3-D freehand SPECT imaging technology called the declipse SPECT open surgery, an intraoperative 3D imaging system for invasive sentinel lymph node biopsy called the declipse SPECTLaparascopy, and a mobile SPECT imaging solution with a high resolution on a small footprint called the declipse SPECT imaging probe. The company also advises clients on medical device development, requirement engineering and software specification for medical devices, software development for medical devices, testing of software for medical devices, and support in the design and conduction of clinical studies.Dr. Jörg Traub founded SurgicEye in 2008, with its headquarters in Munich in Germany.

Portfolio highlights

• Finch — Optimize building design with AI and graph technology. Get immediate feedback on performance, detect errors and find optimal solutions.
• ONEiO — ONEiO is a cloud-native integration service provider connecting people, processes, and tools – enabling seamless collaboration without traditional integration hassle. Provided as a turn-key solution, as self-service, or something in between. You choose.
• Valuebeat — Grow your culture. Backed by data. Platypus is the HR and recruitment tool that measures cultural drivers of people across the organization to help you qualify decisions on hiring and managing your culture.

Portfolio highlights

• Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
• Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.

Portfolio highlights

• BOOST Pharma — Boost Pharma: Developing a stem cell therapy for Osteogenesis Imperfecta.
• Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
• Umecrine Cognition — Umecrine Cognition is a Swedish clinical-stage pharmaceutical company developing a novel class of drugs to treat neurological disorders of the brain.

Portfolio highlights

• N.THING — Established in January 2014, N.THING is a Seoul-based Agri-Food tech company leading innovation in agricultural products, by extension, in the farm-to-table food value chain by combining IoT technology and data. It developed the world’s first modular vertical farm ‘CUBE’ which is easy to expand. N.THING CUBE is a modularized farm with massproductivity where a dedicated OS provides the most optimized environment for each crop so as to create maximized efficiency. N.THING is the world’s first smart farming company that won the iF Design Award, Architecture in 2020. Also, it is a winner of Best of Innovation at the CES 2020 for its excellence in technology, which is the first ever in the agricultural field. N.THING is planning to expand its business on a large scale this year after it successfully completes the PoC process in the U.A.E. Our North American branch office located in New York. N.THING hopes to connect people to nature, things to things, people to things, and people to people through IoT technologies by creating Number of Things out of Nothing. .CUBE : CUBE is internet connected modular container vertical farm. It's an ultimate indoor farm which contains LED technology, real time monitoring system through IoT sensors, collected cultivation data, and upgradable software. We deliver the farm of the desired container form to the desired place.SQUARE : SQUARE is modular hydroponic kit. SQUARE can connect each module and share water. Users can connect as many as they want, grow greens and herbs, and make food great themselves. Each Square consists of four Pickcells, which contains special nutrient-rich sponge. With special sponge and hydroponic, it gives the most simple and effective gardening experience.Planty : Planty is the first Internet-connected social pot in the world. Planty gives pleasure to grow plants with your family, friend, and colleague. Planty enables the user to monitor the environmental information on temperature, soil moisture, and ambient light around plants and give water to plants any me or anywhere.Life : Life is a smart gardening journal aimed at the gardening sector. Plant lovers and gardeners are able to record their gardening activities and information and share them through Social Media. The user can easily insert weather data, location data, gardening activities, and plants’ events. Moreover, all the gardening data can be shared through social media.Sikmulsung: Sikmulsung is our show room to explore 'freshness' of our product and service. It is a place for everyone seeking for 'freshness' in visual, in texture, in taste, in flavor or even in atmosphere with, N.THING's in-store farm, exclusively made for Sikmulsung, special F&B's and our end products.
• MangoBoost — Data Processing Unit (DPU) is a next-generation server accelerator designed to orchestrate various intra-server devices (e.g., CPU, GPU, SSD, NPU, NIC). By maximizing the datacenter’s overall performance and cost efficiency, DPU is now considered as the most important HW/SW solution to realize the next-generation extreme-scale AI serverinfrastructure. However, despite its critical necessity from the datacenter and AI infrastructure, there is no market-leading DPU solution which can meet the customer’s actual demand due to its HW/SW complexity and the application/model heterogeneity. MangoBoost is currently the world’s most highly recognized DPU startup located in US and Korea. We provide the world’s most advanced and flexible DPU HW/SW solutions in order to fully satisfy the needs of various customers. Our DPU HW is fully composable by integrating its rich set of DPU features to construct our customer-optimal DPUs. At the same time, our DPU SW enables to seamlessly deploy the solution to any customer environment. As a result, our DPU solutions are considered very promising to realize the next-generation AI/datacenter infrastructure, and thus they are currently evaluated at various global-leading companies. MangoBoost was founded in early 2022 to commercialize 7 year of top-tier DPU research outcomes achieved at Seoul National University (e.g., many full-system DPU prototypes, many ISCA/MICRO/ASPLOS/OSDI/ATC papers). The current team consists of 45+ system engineers including ~20 top-tier PhDs from Carnegie Mellon University, Seoul National University, POSTECH, U Toronto, and ~20 industry experts from Intel, Microsoft, Samsung, and Naver.
• Aim Intelligence — Leading AI Security & Safety Solutions Provider - Specializing in AI Risk Detection, Mitigation, and Elimination through Advanced Red Teaming and Defensive Systems | Leading provider of AI Security, Safety, and Compliance solutions

Portfolio highlights

• Supira Medical — Next Generation Solution for Temporary Mechanical Circulatory Support Developing a low-profile, high-flow percutaneous ventricular assist device (pVAD) for high risk coronary intervention and cardiogenic shock. Clinical Need Percutaneous ventricular assist devices (pVADs) are placed to provide temporary mechanical support, assisting the native pumping action of
• Callio Therapeutics — Callio Therapeutics focuses on developing next-generation, multi-payload antibody-drug conjugates to maximize therapeutic benefits.
• Newleos Therapeutics — Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines.

Portfolio highlights

• CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
• Caresyntax — Caresyntax is the only enterprise-scale surgical data solution you need to make surgery smarter, safer, and more profitable.
• Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.

Portfolio highlights

• Zama — Secure data privacy of your application with the Zama Concrete framework and its fully homomorphic encryption library
• Inherent — Inherent aims to establish the blueprint for AI-native science while investigating the boundaries of scientific inquiry.
• Lightyear — Lightyear is a simple and approachable way to invest your money globally without unnecessary barriers and fees.

Portfolio highlights

• Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
• Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
• Rewind Therapeutics — Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medicalpractitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.

Portfolio highlights

• BioSilta — BioSilta Ltd. is a privately-held company that utilizes its unique, proprietary EnBase® technology platform to develop innovative, reagent-based EnPresso® growth systems. When compared to conventional growth media, EnPresso growth systems significantly increase the yield of high quality biomolecules from microbial cultures.
• Onbone — Onbone Ltd is a Finnish innovative company working on the field of medical technology. The company develops and markets innovative and user-friendly Woodcast products for orthopaedic and traumatology use. Onbone Ltd has eleven employees and the products are sold in Finland, Germany, Sweden, Holland and Great Britain.

Portfolio highlights

• BQP — BosonQ Psi Pvt. Ltd. (BQP) is a state-of-the-art SaaS-based enterprise software venture leveraging the power of Quantum computing to speed up virtual simulations of Multiphysics and Computer-Aided Engineering (CAE) nature. BosonQ Psi is at the forefront of this quantum revolution. Our vision is to become the premier multiphysics simulation softwareusing quantum computing. Our world-class software suite will include computational science fields of fluid dynamics, structural dynamics, thermal, chemical, and aeroacoustics. With such an innovative product, we will revolutionize the computational world by enabling high-fidelity simulations that are impossible to solve with current computing technology. Further, this product will aid aerospace, automotive, energy, manufacturing, biotechnology, civil engineering, and astrophysics industries in saving millions of dollars by reducing long turnaround times of simulations used in the design process and give higher accuracy to make significant design changes for giving rise to the next generation of an electric car, eVTOL, skyscraper, or even Mars Rover.The possibility to harness the power of quantum computers is endless, and we at BQP thrive on pushing the boundaries of quantum computing technologies to serve our clients. We have made it our mission to bring these possibilities into the hands of every person - from a researcher to a scientist, from a professor to a student. Our name, BosonQ Psi, pays tribute to the great Indian physicist Dr. Satyendra Nath Bose, after whose name the elementary particle in quantum mechanics, Boson, was named and further incorporates the fundamental quantity that describes the state of the quantum particle - Psi, thus symbolizing the company's fundamental goal to contribute in India's goal to be the leader in the Quantum realm and also become a global leader in Quantum paradigm shift in coming years.
• Willow Wealth — Willow Wealth is an alternative investment platform focused on generating income streams for investors. Get exclusive access to private market investments.
• Hubble Network — Connect a Bluetooth device to a global satellite network, delivering affordable, low-power tracking and monitoring for diverse industrial and commercial applications.

Portfolio highlights

• Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
• Bionano Genomics — Discover how Bionano is striving to elevate health and wellness for all through optical genome mapping (OGM) solutions that transform the way the world sees the genome.
• Protego Biopharma — Protego Biopharma develops therapeutics based on the clear human genetic link, excellent human safety profile, proof-of-principle efficacy. The company was founded in 2011 and is headquartered in San Diego, California.

Portfolio highlights

• Gosta Labs — Focus on care
• Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
• Nightingale Health — The most advanced health check for the health industry.

Portfolio highlights

• DrDoctor — We envision a remote-first healthcare system which meets demand without sacrificing care quality, delivered via our Patient Engagement Platform
• Decade Energy — Decade Energy is the energy infrastructure and optimization partner for transport operators and depot managers who want to electrify their fleets.
• Entelo Bio — Precision Medicine

Portfolio highlights

• Arzneimittelwerk Warngau — Unsere Schwerpunkte Karriere bei AMW
• ROTOP — ROTOP is a pharmaceutical company. They manufacture cGMP-compliant radiopharmaceuticals for diagnostics and therapy in the fields of nuclear medicine. They provide API/precursor synthesis, analysis kit development, project management, full regulatory support spect, PET, quality control, and therapy services. Their customers contact throughemail and phone number.
• Salvia BioElectronics — Our mission is to give people with migraine a better life. As a pioneer in the field of medical devices, Salvia BioElectronics is passionately committed to empowering people with migraine to reclaim their lives.

Portfolio highlights

• Newcleo — newcleo is the clean and safe nuclear technology company. Privately funded and headquartered in London, UK, newcleo was launched in 2021 to be a disruptor in the field of nuclear energy. Its mission is to generate safe, clean and inexhaustible energy for the world, through a radically innovative combination of existing, accessible technologies.newcleo is building the next generation system with the goals to: (1) eliminate the need for geological repositories by using a fast neutron flux avoiding production of long life radioactive elements; (2) develop an Accelerator Driven System (ADS), based on the intrinsically safe coupling of a particle accelerator and a sub-critical reactor; (3) accelerate the development of new fuel cycles, including thorium, that provide economic, clean, safe and inexhaustible energy from nuclei and the opportunity to burn the long-lived nuclear waste produced by the old generation of nuclear reactors.With visionary co-founders, newcleo brings together a team of engineers with deep knowledge of nuclear energy with younger recruits with a fresh mindset, working to design an innovative micro Lead Fast Reactor with significant commercial applications, for example in shipping. newcleo wants to be the first step toward the evolution of its industry to become fully respectful of people and the environment. To develop a new, sustainable, and completely safe way of generating nuclear energy that will lead humanity to zero emissions, and to the mitigation of global warming.
• Easy Rain — Leading a new automotive era: our modular ecosystem of virtual sensors and active hardware makes cars and autonomous platforms truly safe in every condition.
• Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.

Portfolio highlights

• ICEYE — Gain access to timely and reliable SAR imaging from the world's leading New Space SAR satellite constellation.
• Vexlum —
• Wirepas — Wirepas offers a standards-based, ultra-reliable mesh connectivity for infrastructure-grade IoT. Proven in millions of devices worldwide.

Portfolio highlights

• WARD — WARD is a fantasy sport game, where fans can watch their favourite eSports matches and predict what will happen in real time.WARD is a startup out of Berlin which has created a “pick and predict” real-time prediction smartphone game, where players can win real prizes. People love to watch e-sports. We believe on these occasions they still want tobe able to participate.However, until now no product has offered anything other than the ability to watch. There’s been no way for fans to spectate, participate, analyse and predict the outcomes of their favourite games.
• MVision AI — AI-powered solutions that automate repetitive tasks, enable efficient radiotherapy workflows, and promote consistency across clinical processes.
• Polka Dot Studio — Kalian Bisa Memasang Taruhan Online Dengan Sangat Mudah Dan Nyaman Di Situs DEWAHOKI Yang Sudah Resmi Di Indonesia

Portfolio highlights

• Mobal — It is time to get your Business Profiles in shape. Meet your customers where they are and stand out where it matters most.
• Remod — Remod provides holistic IT surveys, backup services, cyber control, functional programming, data processing, incident response, secure systems, network design, and proof of concept development.
• Builderhead — Builderhead is an easy-to-use construction management software that helps owners, developers and general contractors complete construction projects on time and within budget.

Portfolio highlights

• Humap — Howspace is an AI-powered online platform that brings digital collaboration and social learning to the forefront of your process & development initiatives.
• PrecisionPhage — PrecisionPhage is a biotech business that specializes on bacteriophage technologies.

Portfolio highlights

• Gizlo — We provide a platform for businesses to connect and collaborate with mobile users around the world, gaining valuable insights and opinions, which matter more than ever.
• Enreach — ZEUS99 Situs Slot Game Resmi Perpaduan Game Demo Wild Bandito Game Online Bertemakan Koboi Barat Dengan Banyak Bonus Menarik Yang Tersedia Di PG Soft Terpercaya
• Film Finances — Discover Film Finances Inc., the global leader in film completion guarantees, ensuring on-schedule and on-budget delivery for over seven decades. Explore our services and industry expertise.

Portfolio highlights

• Surgify — Surgify are currently preparing the commercialization of a novel technology for bone surgery at Aalto University with financial support from Tekes (Finnish Funding Agency for Innovation). To enable continuous communication with clinicians, they have been working in close cooperation with Neurosurgical Department of Helsinki University CentralHospital, part of HUS (The Hospital District of Helsinki and Uusimaa).
• Custom Surgical — Custom Surgical is democratizing hardware and software to record microscope procedures easily and quickly without any professional engineer to attach or cables to share live.
• Hypervision Surgical — Making surgeries more precise, safer and faster. Guiding the future of surgery using AI-powered hyperspectral imaging.

Portfolio highlights

• Surgify — Surgify are currently preparing the commercialization of a novel technology for bone surgery at Aalto University with financial support from Tekes (Finnish Funding Agency for Innovation). To enable continuous communication with clinicians, they have been working in close cooperation with Neurosurgical Department of Helsinki University CentralHospital, part of HUS (The Hospital District of Helsinki and Uusimaa).

Portfolio highlights

• RNatives — RNatives specializes in the field of biotechnology, focusing on the development of innovative RNA-based therapies. The company's expertise lies in RNA activation, particularly targeting VEGFA for the treatment of cardiovascular diseases. RNatives is dedicated to advancing its lead programs through rigorous research and development, aiming tooffer novel therapeutic options for conditions with unmet medical needs. With a team of skilled professionals, RNatives is committed to pushing the boundaries of biotechnology to improve patient outcomes.

Portfolio highlights

• Incirt — Incirt provides modulation bandwidth and highly energy-efficient data converter IP solutions, exploiting a novel, ground-breaking technology approach. They offer relevant applications including mmWave 5G, and 6G.
• Atriva Therapeutics — Therapies against viral infections. First-in-class host-targeting therapies to treat respiratory viral infections, including COVID-19 and influenza.
• OMEICOS Therapeutics — OMEICOS Therapeutics is developing a novel, first-in-class, small molecule utilizing a new Mode of Action. OMEICOS' novel therapeutic strategy is based upon the discovery of natural metabolites of omega-3 fatty acids that mediate a strong anti-arrhythmic effect. In contrast to all other anti-arrhythmic drugs, OMEICOS' substances activatean endogenous cardio-protective signaling pathway that not only stabilizes the heart rhythm but shall provide curative effects to the diseased organ by preventing its electrical and structural remodeling.

Portfolio highlights

• Sensolus — Sensolus provides care-free tracking of your valuable non-powered assets directly from the cloud.Sensolus offers turnkey solutions for wireless, low-power context-aware sensing. Sensolus developed a personal product line of low-power tracker systems called STICKNTRACK.Sensolus is built upon many years of expertise in low-power networks,wireless sensor design, cloud-based sensor management, analytics, and applications.
• Delft Advanced Biorenewables — We enable the bio-economy by improving the productivity of fermentations with our in-situ product recovery (ISPR) technology.
• Trillium Renewable Chemicals — Trillium Renewable Chemicals manufactures chemicals from renewable feedstocks used in a variety of industrially important applications. The company was founded in 2021 and based in Knoxville, Tennessee.

Portfolio highlights

• DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
• Ceva Santé Animale — Ceva Sante Animale S.A. engages in the research, development, production, and marketing of pharmaceutical products and vaccines for companion and farm animals. They work with welfare and social programmes around the world to bring this vision to life – anywhere their products and know-how can make a difference and with all kinds of partners. FromUganda, working with small-scale livestock owners and vets to stop sleeping sickness in its tracks, to the UK and USA, where they supply the biggest animal welfare charities with Adaptil® collars to help re-home shelter dogs.
• CorFlow Therapeutics — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.

Portfolio highlights

• Neon Health — Neon accelerates patient access to critical care by jumping through all the hoops to onboard and adhere to life-saving drugs, treatments.
• Auxira Health — Auxira Health is committed to providing virtual practice extensions that seem like a natural extension of your team, bringing order to the chaos of modern healthcare.
• G-Tech Medical — G-Tech Medical is developing a wireless, wearable, disposable electrode patch to measure the electrical activity from the stomach, small intestine and colon. Most patients with abdominal pain, constipation, diarrhea or bloating have functional disorders that are not diagnosed with colonoscopies or CT scans. G-Tech's GutCheck patch will measuremotor activity and thus evaluate motility to allow physicians to better target the treatment.

Portfolio highlights

• Marginum — Pioneering the next-generation quantitative surgical techniques.
• Elucida Oncology — Elucida Oncology focuses on transforming outcomes for patients with primary solid tumors and metastatic cancer. The company utilizes the novel target or clear capabilities of its ultra-small C-Dot cancer-targeting particle platform across diagnostic imaging, surgical, and a wide range of therapeutic applications.
• Bone Index Finland — Bindex® is – in addition to DXA devices – the only device that can be used for osteoporosis diagnostics with international guidelines (ISCD) and the Finnish Current Care Guidelines (04/2014).Bindex® is applied by measuring the cortical thickness of tibia. The results, combined with other patient data, are used to estimate the hip region’sbone mineral density. Bone mineral density values (g/cm2) are normally only received via the large DXA devices used in hospitals.Bindex®’s quickness and simplicity make its use possible in high volume risk group screenings. It makes the identification of an osteoporosis risk possible before the first bone fracture has even occurred. Thus, it both improves the patient’s quality of life and saves on public health care expenses.

Portfolio highlights

• VALIDIO — Real-time data validation and data quality monitoring for modern data teams. Abstracting complexity away from data engineering.
• Camphouse — Mediatool is the all-in-one planning, execution, tracking and reporting tool for media and marketing campaigns. Increase productivity with streamlined delivery and better collaboration across all your marketing activities. Grow revenue with confidence, using real-time performance data to optimise investment.Hundreds of tangible benefits, onebetter way of working. Forget spreadsheets and get to know Mediatool.
• Galdera Labs — Disposable financial models cost more than time. They cost context. Galdera was built for growth finance teams looking to save both.

Portfolio highlights

• Ribbon Bio —
• Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
• TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.

Portfolio highlights

• VideoVisit — VideoVisit is a Nordic health technology company, developing digital solutions for home care and healthcare sectors. They make healthcare available to everyone, anywhere and anytime, and strive to provide solutions that help people live independently at home for as long as possible. They collaborate with healthcare specialists to ensure that oursolutions are available to everyone.
• Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
• Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol

Portfolio highlights

• Plasmacure — Plasmacure develops innovative plasma technology for wound care. Discover how cold plasma is transforming the treatment of chronic wounds.
• Mirantus Health — Mirantus is building a distributed healthcare provider to improve access to care for underserved patients. Through healthcare services (Mirantus Care) and cloud-solutions (Mirantus OS), Mirantus empowers doctors to efficiently treat patients who were difficult to reach before. This improves healthcare access for patients, allows physicians to earnmore, while saving payors billions in downstream costs. Mirantus is on a mission to get every specialist physician in Europe to participate in distributed healthcare, to improve healthcare access for 100M+ underserved patients.
• Alba Health — Discover your baby's gut health & microbiome for the best start in life.

Portfolio highlights

• CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
• Recornea — Recornea is a developer of a corneal medical device to restore the physiological curvature of the cornea with clear and predictable clinical outcomes.
• Health Triage — Health Triage researches, designs, and develops clinical data, new technologies, and applications for the health sector. Their research activities focus on the development of new screening protocols and innovative diagnosis processes, exploiting deep learning to facilitate the acquisition of new technologies through data learned from algorithms andneural networks.

Portfolio highlights

• Augmedics — Augmedics is a provider of augmented reality (AR) surgical image guidance solutions. Augmedics seeks to improve healthcare by developing cutting-edge technologies that will revolutionize surgical treatment. The company’s first product, the xvision-spine (XVS) system, is an augmented-reality surgical navigation system designed to allow surgeons tosee and navigate inside a patient’s body during complex procedures.
• Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.

Portfolio highlights

• Valo Therapeutics — Valo Therapeutics is an immunotherapy company that is developing antigen-coated oncolytic viruses as anti-cancer therapeutic vaccines. The Valo Tx platform, PeptiCRAd (Peptide-coated Conditionally Replicating Adenovirus), was developed out of the laboratory of Professor Vincenzo Cerullo at the University of Helsinki. It turns oncolytic adenovirusesinto targeted tissue specific cancer vaccines without the need to generate and manufacture multiple genetically modified viruses. The company is also developing PeptiENV, among other neoantigen strategies, in collaboration with Professor Cerullo. PeptiENV is expected to improve the therapeutic response to enveloped oncolytic viruses in the treatment of multiple forms of cancer.

Portfolio highlights

• Octozi — AI agents to accelerate clinical development workflows for the pharma industry.
• VivoSense — Scientific consulting and data analysis for wearable sensor solutions that advance clinical research.
• ModernVivo — New drugs fail in human clinical trials 90% of the time. These failures can be traced directly back to the consistent inability of preclinical animal studies to predict clinical success. Yet the design process for preclinical animal studies has remained largely unchanged for decades; scientists read a tiny fraction of published literature and writetheir experimental protocols in 2-4 weeks. This time-consuming, tedious process is not only a major pain point for in-vivo scientists but leads to substantial experimental design flaws, resulting in unreliable data with which billion-dollar decisions are made. Scientists we’ve spoken to repeatedly express their struggle with the overwhelming amount of preclinical information they need to sift through in order to design experiments. At ModernVivo, we are revolutionizing this antiquated process by equipping scientists with tools that enable them to write in-vivo protocols more effectively. Our technology empowers scientists to streamline their work, accelerating drug development timelines.

Portfolio highlights

• DriveU.auto — Transform existing terminal tractors into autonomous vehicles. Fast ROI. Continuous operation in mixed traffic.
• Pionix — open source software as a service for charging stations / e-mobility
• piur imaging — PIUR´s tomographic ultrasound solutions turn any standard ultrasound system into a tomographic 3D imaging device, bridging the gap between 2D ultrasound and regular tomographic imaging modalities. With any conventional 2D ultrasound transducer, high-resolution tomographic images can be generated and stored as quantifiable volumes, enabling true AIpost-processing for efficient diagnostics. Current focus is on thyroid imaging where AI algorithms allow doctors a fast and objective analysis and classification of thyroid nodules.

Portfolio highlights

• Mondego Bio — Headquartered in Portugal’s main biotech park, Biocant, Mondego Bio is developing best-in-class protein tyrosine phosphatase non-receptor type 2 (PTPN2) inhibitors, providing a potential immuno-oncological therapy with an improved safety and tolerability profile.
• BIMINI Biotech — BIMINI Biotech is a startup that develops innovative therapeutic strategies for oncology. It is developing therapeutic strategies that target the growth hormone receptor (GHR) and its interaction with insulin-like growth factor 1 (IGF-1) for oncology, metabolic diseases, and aging.The company was founded in 2019 and is based in Leiden, TheNetherlands.
• Chromis Therapeutics — Chromis Therapeutics, Inc. (Chromis) is a San Diego-based biopharmaceutical company, focused on the development of curative treatments for chronic HBV infection, based on its advanced proprietary drug design and discovery platform. The company is seeking investment to advance its novel cccDNA inhibitor (CHR101), viral entry and viral capsidassembly inhibitor lead candidates for the treatment of chronic HBV. CHR101 has a potential to eradicate HBV and to efficiently cure chronically infected HBV patients, as compared to drugs currently on the market. CHR101's activity is supported by a robust discovery preclinical data package.